ACCP, Sunovion Partner on COPD Drug Delivery
The strategic initiative will focused on increasing recognition that the way a medicine is delivered in evaluating a patient’s COPD therapy.
Tag: Sunovion
All
Latest
ACCP, Sunovion Partner on COPD Drug Delivery
The strategic initiative will focused on increasing recognition that the way a medicine is delivered in evaluating a patient’s COPD therapy.
Read MoreSunovion Submits NDA for COPD Treatment
Sunovion Pharmaceuticals has submitted a New Drug Application to the FDA for approval of Sun-101/eFlow, a maintenance treatment for COPD.
Read More
CHEST and Sunovion Focus on Hispanic COPD Awareness
As part of COPD Awareness Month in November, the CHEST Foundation and Sunovion Pharmaceuticals are encouraging Hispanics to learn more about COPD, and if they are at risk, to get tested.
Read More
Sunovion Presents Positive Data for its SUN-101 COPD Drug
SUN-101 (glycopyrrolate inhalation solution) produced statistically and clinically significant changes in forced expiratory volume in one second (trough FEV1) in bronchodilation.
Read MoreSunovion to Present Data for COPD Drug at CHEST 2014
Sunovion Pharmaceuticals Inc will present new data highlighting the efficacy and safety results of SUN-101 (glycopyrrolate inhalation solution), a long-acting muscarinic antagonist (LAMA) bronchodilator in development for the treatment of COPD.
Read More
CHEST, Sunovion To Increase COPD Awareness for US Hispanics
“Tome Un Respiro” is a Spanish-language campaign to raise awareness among Hispanics in the US about the prevalence, treatment options, and disease management of COPD.
Read More
AmeriCares Provides $2.4M in Respiratory Medication to the Uninsured
The nonprofit health organization teamed with Sonovion Pharmaceuticals and AstraZeneca for National Asthma and Allergy Awareness month to provide medicine to uninsured and underinsured patients.
Read More